Sign Up to like & get
recommendations!
0
Published in 2019 at "Current computer-aided drug design"
DOI: 10.2174/1573409915666190918150136
Abstract: BACKGROUND Glutaminyl cyclase (QC) is a novel target in the battle against Alzheimer's disease, a highly prevalent neurodegenerative disorder. QC inhibitors have the potential to be developed as therapeutically useful anti-Alzheimer's disease agents. METHODS Linear…
read more here.
Keywords:
glutaminyl cyclase;
alzheimer disease;
imidazole based;
qsar modeling ... See more keywords